HomeAbout

TL;DR CNBC


Brazil institute says vaccine from China's Sinovac has efficacy above 50%, but delays full results again - TL;DR CNBC

Brazil institute says vaccine from China's Sinovac has efficacy above 50%, but delays full results again

Publishing timestamp: 2020-12-24 02:19:51


Summary


Sentiment: NEGATIVE

Tickers: AZN-GBPFEBNTXSVAMRNA

Keywords:

Source: https://www.cnbc.com/2020/12/24/brazil-institute-says-coronavac-efficacy-above-50percent-but-delays-full-results.html


Developed by Leo Phan